Nikki Ryan

Suggest Changes
  • Citations Per Year
Learn More
Reversible late onset neutropenia associated with rituximab has been reported with incidence rates varying from 15 to 70% in B cell lymphoma patients receiving autologous stem cell transplantation.(More)
  • 1